LGA
GSK icon

Lebenthal Global Advisors’s GSK GSK Stock Holding History

Lebenthal Global Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-152
Closed -$6K – 300
2020
Q4 		$6K Buy
+152
New +$6.98K ﹤0.01% 477

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Lebenthal Global Advisors's GSK Position: Q1 2021 in Review

Lebenthal Global Advisors sold out of GSK (GSK) in Q1 2021, closing a stake of 152 shares — an estimated $6K sold.

Lebenthal Global Advisors first reported a position in GSK in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • Lebenthal Global Advisors reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
  • Lebenthal Global Advisors sold 152 GSK shares in Q1 2021, an estimated $6K.
  • Lebenthal Global Advisors first reported a position in GSK in Q4 2020 and held it in 1 quarter.
  • Lebenthal Global Advisors's GSK position peaked at $6K in Q4 2020.
  • 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Lebenthal Global Advisors's 13F filing for Q1 2021, filed 7 May 2021.